Alhamadani, I., Alzyadi, M. and Majeed, M. 2026. Prognostic Significance of the CXCL11/CXCL9/CD163 Immune Signature in Triple-Negative Breast Cancer: A Bioinformatics and Survival Analysis: CXCL11/CXCL9 prognostic value. Archives of Breast Cancer. 13, 2 (Apr. 2026), 154–165. DOI:https://doi.org/10.32768/abc.6274819305-647.